| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/03/2005 | US20050048486 Method of inactivating ribonucleases at high temperature |
| 03/03/2005 | US20050048485 Novel nucleic acid probe and novel method of assaying nucleic acid using the same |
| 03/03/2005 | US20050048482 Method of estimating the genotype of fertility recovery locus to rice bt type male fertility cytoplasm |
| 03/03/2005 | US20050048481 Markers for detecting plant genome polymorphism with the use of transposable element and method of constructing the same |
| 03/03/2005 | US20050048480 Method of detecting cancer |
| 03/03/2005 | US20050048479 Adenylyl and guanylyl cyclases |
| 03/03/2005 | US20050048477 Reagents and methods for detection and characterization of protein-protein interactions, nuclear export and localization sequences and inducible gal4p-mediated gene expression in yeast |
| 03/03/2005 | US20050048475 Materials and methods for detection of enterovirus and norovirus |
| 03/03/2005 | US20050048474 Process and apparatus for separating and recovering particles from a liquid sample |
| 03/03/2005 | US20050048473 Using protease digestion as diagnostic tool in detection of viral particles associated with severe acute respiratory syndrome (SARS) |
| 03/03/2005 | US20050048470 Expression vector comprising nucleotide sequences coding recombinase inhibitor for use in treatment and prevention of viral infcetion and diseases |
| 03/03/2005 | US20050048467 Method and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin |
| 03/03/2005 | US20050048465 Method of collecting nasopharyngeal cells and secretions for diagnosis of viral upper respiratory infections and screening for nasopharyngeal cancer |
| 03/03/2005 | US20050048464 Method of screening candidate compounds for susceptibility to biliary excretion |
| 03/03/2005 | US20050048463 Using gene expression profiling and quantification as diagnostic tool in descriminating/distinguishing cell types present in heterogenous cell populations |
| 03/03/2005 | US20050048462 Using excitatory amino acid as tools in detection as well as evaluation of activated synapsis; screening for compounds which treat epilepsy, neurodegeneration, ischemia, migraines, schizophrenia and/or depression; cognition activators |
| 03/03/2005 | US20050048166 Contacting meat with protease having high activity on troponin, myosin |
| 03/03/2005 | US20050048080 Soaking the sea algae/halophytes in an aqueous solution containing acid to reduce mineral content, separating the treated sea algae/halophvte from the aqueous solution that contains the dissolved mineral removed from the sea algae/halophvte |
| 03/03/2005 | US20050048075 Protein isolation |
| 03/03/2005 | US20050048073 Methods of determining west nile virus epitopes and method of using the same |
| 03/03/2005 | US20050048070 Mixture of polypeptides from cytokeratins; anticancer agnets; vaccines |
| 03/03/2005 | US20050048062 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 03/03/2005 | US20050048052 Bioassay for detecting expression of mammalian CC-chemokine receptor 2, by binding of antibody or antigen-binding fragment; human or humanized monoclonal antibody; test kits |
| 03/03/2005 | US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections |
| 03/03/2005 | US20050047998 Phosphoprotein target for insulin and its antagonists |
| 03/03/2005 | US20050047996 Calibration of colorectal cancer; gene expression profile; administering to human an antibody which binds to protein markers |
| 03/03/2005 | US20050047973 Fully automated and parameter regulated; simultaneous performance of polymerase chain reaction and microarray based testing in single chamber system; simple construction, low manufacturing cost; reproducibility; preventing contamination |
| 03/03/2005 | US20050047640 Method and device for selectively targeting cells within a three-dimensional specimen |
| 03/03/2005 | US20050046833 Gigamatrix holding tray having through-hole wells |
| 03/03/2005 | US20050045476 Systems and methods for blood glucose sensing |
| 03/03/2005 | US20050045063 Marking solution for counterfeit-resistant identification of a valuable object, marking produced by the marking solution and method for marking a valuable object |
| 03/03/2005 | DE10337368A1 Diagnosis of pancreatic cancer by detecting expression of the a disintegrin and metalloprotease domain 9 (ADAM9) protein using specific antibodies, also therapeutic use of these antibodies and of ADAM9-specific nucleic acids |
| 03/03/2005 | DE10336760A1 Method for in vivo labeling of defined cell types in a tissue, useful for detecting specific cells and to establish expression profiles, by providing cell-specific expression of fluorescent protein |
| 03/03/2005 | DE10335107A1 Preparing nucleic acid reaction mixture for analysis on a microarray comprises binding cDNA to membrane, washing, drying and eluting, synthesizing cRNA and binding to membrane before washing, drying and eluting |
| 03/03/2005 | DE10321480A1 Verfahren zur Identifizierung von Zellinien A process for the identification of cell lines |
| 03/03/2005 | DE102004036765A1 Maskieren von chemischen Arrays Masking chemical arrays |
| 03/03/2005 | CA2536635A1 Novel fungal proteins and nucleic acids encoding same |
| 03/03/2005 | CA2536408A1 Improved antibodies having altered effector function and methods for making the same |
| 03/03/2005 | CA2536388A1 Methods and systems for profiling biological systems |
| 03/03/2005 | CA2536359A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 03/03/2005 | CA2536112A1 Methods for enhancing embryo viability |
| 03/03/2005 | CA2536071A1 Methods for detecting regulatory effect on synoviolin activity |
| 03/03/2005 | CA2536062A1 Methods for reducing complexity of a sample using small epitope antibodies |
| 03/03/2005 | CA2535969A1 Methods and compositions comprising fatp5 for use in the diagnosis and treatment of metabolic disorders |
| 03/03/2005 | CA2535921A1 Novel rat calcium channel subunits and related probes, cell lines and methods |
| 03/03/2005 | CA2535799A1 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 03/03/2005 | CA2535754A1 Human autism susceptibility gene and uses thereof |
| 03/03/2005 | CA2535585A1 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby |
| 03/03/2005 | CA2531400A1 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 03/03/2005 | CA2531146A1 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 03/03/2005 | CA2530821A1 Hiv immunogenic complexes |
| 03/03/2005 | CA2523658A1 Rnai agents for anti-sars coronavirus therapy |
| 03/03/2005 | CA2501155A1 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 03/02/2005 | EP1510823A2 Containers for performing polymerase chain reaction |
| 03/02/2005 | EP1510821A1 Diagnosis and treatment of mycobacterial infections |
| 03/02/2005 | EP1510820A1 Method for detecting medically relevant conditions in a solubilized LBC sample |
| 03/02/2005 | EP1510817A1 Microencapsulation of oxygen-sensing particles |
| 03/02/2005 | EP1510588A1 Correlation of the ratio of thymidine phosphorylase and dihydropyrimidine dehydrogenase mRNA expression levels in colorectal cancer with disease-free survival in 5-FU treated patients |
| 03/02/2005 | EP1510587A1 Nucleic acid amplification primers for detecting cytokeratins and examination method with the use of the primers |
| 03/02/2005 | EP1510578A2 Simultaneous isolation and quantitation of dna |
| 03/02/2005 | EP1510576A1 Methods of identifying nucleic acids |
| 03/02/2005 | EP1510575A1 Method of typing gene polymorphisms |
| 03/02/2005 | EP1510574A2 Transposon-like element in rye |
| 03/02/2005 | EP1510555A1 8-(anilino)-1-naphthalenesulfonate analogs and their use in analyte detection assays |
| 03/02/2005 | EP1510219A1 Method for identifying at least one Aminopeptidase-inhibitor |
| 03/02/2005 | EP1509773A1 Diagnostics and therapeutics for diseases associated with chemokine receptor 11 (ccr11) |
| 03/02/2005 | EP1509772A2 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 03/02/2005 | EP1509768A2 Methods for cohort selection and longevity studies |
| 03/02/2005 | EP1509625A2 Procede de detection simultanee de reactions d'hybridation et immunologiques |
| 03/02/2005 | EP1509624A2 Met/fret based method of target nucleic acid detection whereby the donor/acceptor moieties are on complementary strands |
| 03/02/2005 | EP1509623A2 Amplification of ribonucleic acids |
| 03/02/2005 | EP1509622A1 Fluorescence polarization detection of nucleic acids |
| 03/02/2005 | EP1509621A1 Treatment with cytokines for alzheimer's disease |
| 03/02/2005 | EP1509620A2 Direct pcr quantification |
| 03/02/2005 | EP1509619A2 Pyrophosphorolysis activated polymerization (pap) |
| 03/02/2005 | EP1509618A2 Autoimmune conditions and nadph oxidase defects |
| 03/02/2005 | EP1509617A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 03/02/2005 | EP1509616A1 Method of detecting arcenic ions with indicator bacteria |
| 03/02/2005 | EP1509615A1 Screening method for regulatory enzymes employing tribrid (tri-hybrid) system |
| 03/02/2005 | EP1509614A1 Map-kinase inhibitors as regulators of tumor-associated antigen expression |
| 03/02/2005 | EP1509607A1 Immunogenic sequences |
| 03/02/2005 | EP1509606A1 Allergen from mugwort pollen |
| 03/02/2005 | EP1509603A1 Methods, compositions and kits for cell separation |
| 03/02/2005 | EP1509601A1 Fluorescent detection of peroxidase enzymes |
| 03/02/2005 | EP1509596A1 Translocation dependent complementation for drug screening |
| 03/02/2005 | EP1509542A1 Methods for measuring kinase activity and phosphatase activity |
| 03/02/2005 | EP1509540A2 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 03/02/2005 | EP1509539A2 Novel compositions and methods for cancer |
| 03/02/2005 | EP1509537A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 03/02/2005 | EP1509310A1 Cell recovery |
| 03/02/2005 | EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/02/2005 | EP1509247A1 Use of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating dieseases |
| 03/02/2005 | EP1509240A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 03/02/2005 | EP1509230A2 Method of treating cancer using kinase inhibitors |
| 03/02/2005 | EP1509087A2 Treatment for diabetes |
| 03/02/2005 | EP1451320A4 Materials and methods for releasing genetic material |
| 03/02/2005 | EP1444331A4 Novel cell-based assays for g-protein-coupled receptor-mediated activities |
| 03/02/2005 | EP1432823A4 Mitochondrial biology expression arrays |
| 03/02/2005 | EP1390548A4 Cells for detection of enteroviruses |
| 03/02/2005 | EP1252335A4 Signaling aptamers that transduce molecular recognition to a differential signal |